Press Releases

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021

September 3, 2021 at 7:00 AM EDT

PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in September:

  • Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 3:30 p.m. E.T.
  • Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)
  • Cantor Global Healthcare Conference 2021 on Monday, September 27, 2021 at 8:40 a.m. E.T.

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at, and follow us on Twitter and LinkedIn.


Andrew Faughnan
Executive Director, Investor Relations
(609) 662-3809

Diana Moore
Head of Global Corporate Communications
(609) 662-5079